NCT06879366View on ClinicalTrials.gov

Evaluation of the Efficacy of Aloe-Vera el Versus Bezydamine Hydrochloride in the Prevention of Radiation Induced Oral Mucositis A Randamized Controlled Clinical Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

December 1, 2024

Study Completion Date

March 1, 2025

Conditions
Head and Neck Cancer Patients Treated With Radiotherapy
Interventions
DRUG

Aloe vera gel

10% aloe-vera gel will be prepared under well-controlled laboratory checks

DRUG

Benzydamine Hydrochloride 0.15% Oral gel

Benzydamine Hydrochloride 0.15% Oral gel

Trial Locations (1)

Unknown

Cairo University, Cairo

All Listed Sponsors
lead

October 6 University

OTHER

NCT06879366 - Evaluation of the Efficacy of Aloe-Vera el Versus Bezydamine Hydrochloride in the Prevention of Radiation Induced Oral Mucositis A Randamized Controlled Clinical Trial | Biotech Hunter | Biotech Hunter